ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

Paul Marks To Chair Search Committee For NCI Director

January 20, 1995

Scientists Tell Panel: Peer Review Need Improving, Available Funds Should Be Spread Over More Grants

April 30, 1982

Philadelphia Group Begins BMT Trial for Breast Cancer

April 5, 1991

Mayo Clinic Cancer Center Wins NCI Support Grant Renewal

June 19, 2009

State Cancer Incidence Report Published by NCI, CDC

November 22, 2002

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980